Snowden Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.42M | Sell |
43,299
-37,496
| -46% | -$3.02M | 0.08% | 245 |
|
|
2026
Q1 | $7.06M | Buy |
80,795
+21,936
| +37% | +$2.1M | 0.19% | 109 |
|
|
2025
Q4 | $5.7M | Buy |
58,859
+1,983
| +3% | +$193K | 0.15% | 145 |
|
|
2025
Q3 | $5.46M | Sell |
56,876
-2,123
| -4% | -$195K | 0.15% | 141 |
|
|
2025
Q2 | $5.18M | Buy |
58,999
+4,732
| +9% | +$401K | 0.15% | 143 |
|
|
2025
Q1 | $4.91M | Buy |
54,267
+10,688
| +25% | +$956K | 0.16% | 146 |
|
|
2024
Q4 | $3.51M | Buy |
43,579
+1,374
| +3% | +$119K | 0.11% | 193 |
|
|
2024
Q3 | $3.83M | Sell |
42,205
-4,749
| -10% | -$400K | 0.11% | 210 |
|
|
2024
Q2 | $3.73M | Buy |
46,954
+11
| +0% | +$902 | 0.11% | 217 |
|
|
2024
Q1 | $4.12M | Buy |
46,943
+2,595
| +6% | +$221K | 0.13% | 207 |
|
|
2023
Q4 | $3.65M | Sell |
44,348
-3,559
| -7% | -$271K | 0.14% | 203 |
|
|
2023
Q3 | $3.75M | Sell |
47,907
-1,226
| -2% | -$103K | 0.16% | 182 |
|
|
2023
Q2 | $4.33M | Buy |
49,133
+1,939
| +4% | +$167K | 0.15% | 180 |
|
|
2023
Q1 | $3.8M | Buy |
47,194
+14,166
| +43% | +$1.15M | 0.15% | 182 |
|
|
2022
Q4 | $2.57M | Sell |
33,028
-7,199
| -18% | -$583K | 0.11% | 232 |
|
|
2022
Q3 | $3.25M | Buy |
40,227
+6,257
| +18% | +$562K | 0.15% | 179 |
|
|
2022
Q2 | $3.05M | Buy |
33,970
+3,163
| +10% | +$320K | 0.14% | 193 |
|
|
2022
Q1 | $3.42M | Buy |
30,807
+16,333
| +113% | +$1.73M | 0.14% | 191 |
|
|
2021
Q4 | $1.5M | Sell |
14,474
-13,497
| -48% | -$1.56M | 0.08% | 273 |
|
|
2021
Q3 | $3.51M | Buy |
27,971
+2,578
| +10% | +$334K | 0.17% | 172 |
|
|
2021
Q2 | $3.15M | Buy |
25,393
+3,603
| +17% | +$452K | 0.16% | 185 |
|
|
2021
Q1 | $2.57M | Buy |
21,790
+5,232
| +32% | +$613K | 0.15% | 205 |
|
|
2020
Q4 | $1.94M | Buy |
16,558
+2,590
| +19% | +$285K | 0.13% | 217 |
|
|
2020
Q3 | $1.45M | Sell |
13,968
-2,741
| -16% | -$275K | 0.12% | 219 |
|
|
2020
Q2 | $1.53M | Buy |
16,709
+287
| +2% | +$27.5K | 0.13% | 211 |
|
|
2020
Q1 | $1.48M | Buy |
16,422
+1,422
| +9% | +$151K | 0.16% | 193 |
|
|
2019
Q4 | $1.7M | Buy |
15,000
+1,267
| +9% | +$139K | 0.15% | 200 |
|
|
2019
Q3 | $1.49M | Buy |
13,733
+3,732
| +37% | +$389K | 0.15% | 204 |
|
|
2019
Q2 | $974K | Buy |
10,001
+126
| +1% | +$11.5K | 0.1% | 251 |
|
|
2019
Q1 | $899K | Buy |
9,875
+1,209
| +14% | +$108K | 0.1% | 259 |
|
|
2018
Q4 | $788K | Buy |
8,666
+2,364
| +38% | +$221K | 0.1% | 256 |
|
|
2018
Q3 | $620K | Buy |
6,302
+2,677
| +74% | +$247K | 0.07% | 299 |
|
|
2018
Q2 | $310K | Buy |
3,625
+109
| +3% | +$9.1K | 0.04% | 356 |
|
|
2018
Q1 | $282K | Sell |
3,516
-101
| -3% | -$8.33K | 0.04% | 331 |
|
|
2017
Q4 | $292K | Sell |
3,617
-55
| -1% | -$4.41K | 0.04% | 335 |
|
|
2017
Q3 | $286K | Buy |
3,672
+410
| +13% | +$34K | 0.05% | 321 |
|
|
2017
Q2 | $290K | Buy |
3,262
+702
| +27% | +$59.2K | 0.05% | 289 |
|
|
2017
Q1 | $206K | Buy |
+2,560
| New | +$200K | 0.05% | 323 |
|
Other funds holding MDT
Snowden Capital Advisors's MDT Position: Q2 2026 in Review
Snowden Capital Advisors reduced its Medtronic (MDT) stake by 46% in Q2 2026, selling an estimated $3.02M and leaving 43,299 shares worth $3.42M. The position accounts for 0.08% of the portfolio, ranked #245.
Snowden Capital Advisors first reported a position in MDT in Q1 2017 and has held it in 38 quarters since. The position peaked at $7.06M in Q1 2026. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Snowden Capital Advisors held 43,299 shares of Medtronic worth $3.42M as of Q2 2026.
- Snowden Capital Advisors sold 37,496 Medtronic shares in Q2 2026, an estimated $3.02M.
- Medtronic made up 0.08% of Snowden Capital Advisors's portfolio in Q2 2026, its #245 holding.
- Snowden Capital Advisors first reported a position in Medtronic in Q1 2017 and has held it in 38 quarters since.
- Snowden Capital Advisors's Medtronic position peaked at $7.06M in Q1 2026.
- 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.